Viewing Study NCT05562934


Ignite Creation Date: 2025-12-25 @ 2:36 AM
Ignite Modification Date: 2026-04-23 @ 4:20 AM
Study NCT ID: NCT05562934
Status: COMPLETED
Last Update Posted: 2025-10-24
First Post: 2022-09-28
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.
Sponsor: Novartis Pharmaceuticals
Organization: